Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1

被引:0
|
作者
François Bertucci
Anthony Gonçalves
机构
[1] Institut Paoli-Calmettes,Department of Medical Oncology
[2] Department of Molecular Oncology,Faculty of Medicine
[3] Centre de Recherche en Cancérologie de Marseille (CRCM),undefined
[4] CNRS U7258,undefined
[5] INSERM U1068,undefined
[6] Aix-Marseille University,undefined
来源
Current Oncology Reports | 2017年 / 19卷
关键词
Breast cancer; Expression; Immune response; Monoclonal antibodies; PD-1; PD-L1;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] Immunotherapy in Breast Cancer: the Emerging Role of PD-1 and PD-L1
    Bertucci, Francois
    Goncalves, Anthony
    CURRENT ONCOLOGY REPORTS, 2017, 19 (10)
  • [2] Emerging Role of Ubiquitination in the Regulation of PD-1/PD-L1 in Cancer Immunotherapy
    Hu, Xiaoli
    Wang, Jing
    Chu, Man
    Liu, Yi
    Wang, Zhi-wei
    Zhu, Xueqiong
    MOLECULAR THERAPY, 2021, 29 (03) : 908 - 919
  • [3] Emerging role of ubiquitination/ deubiquitination modification of PD-1/PD-L1 in cancer immunotherapy
    Ding, Peng
    Ma, Zhiqiang
    Fan, Yizeng
    Feng, Yingtong
    Shao, Changjian
    Pan, Minghong
    Zhang, Yimeng
    Huang, Di
    Han, Jing
    Hu, Yi
    Yan, Xiaolong
    GENES & DISEASES, 2023, 10 (03) : 848 - 863
  • [4] PD-L1/PD-1 blockade in breast cancer: The immunotherapy era
    Li, Chia-Jung
    Lin, Li-Te
    Hou, Ming-Feng
    Chu, Pei-Yi
    ONCOLOGY REPORTS, 2021, 45 (01) : 5 - 12
  • [5] PD-1/PD-L1 and immunotherapy for pancreatic cancer
    Feng, Mengyu
    Xiong, Guangbing
    Cao, Zhe
    Yang, Gang
    Zheng, Suli
    Song, Xujun
    You, Lei
    Zheng, Lianfang
    Zhang, Taiping
    Zhao, Yupei
    CANCER LETTERS, 2017, 407 : 57 - 65
  • [6] Current status of PD-1/PD-L1 blockade immunotherapy in breast cancer
    Noguchi, Emi
    Shien, Tadahiko
    Iwata, Hiroji
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2021, 51 (03) : 321 - 332
  • [7] Adipose PD-L1 Modulates PD-1/PD-L1 Checkpoint Blockade Immunotherapy Efficacy in Breast Cancer
    Wu, Bogang
    Sun, Xiujie
    Gupta, Harshita B.
    Yuan, Bin
    Li, Jingwei
    Ge, Fei
    Chiang, Huai-Chin
    Zhang, Xiaowen
    Zhang, Chi
    Zhang, Deyi
    Yang, Jing
    Hu, Yanfen
    Curiel, Tyler J.
    Li, Rong
    ONCOIMMUNOLOGY, 2018, 7 (11):
  • [8] PD-L1 expression and PD-1/PD-L1 inhibitors in breast cancer
    Monneur, Audrey
    Goncalves, Anthony
    Bertucci, Francois
    BULLETIN DU CANCER, 2018, 105 (03) : 261 - 272
  • [9] PD-1/PD-L1 pathway: Basic biology and role in cancer immunotherapy
    Salmaninejad, Arash
    Valilou, Saeed Farajzadeh
    Shabgah, Arezoo Gowhari
    Aslani, Saeed
    Alimardani, Malihe
    Pasdar, Alireza
    Sahebkar, Amirhossein
    JOURNAL OF CELLULAR PHYSIOLOGY, 2019, 234 (10) : 16824 - 16837
  • [10] The role of lncRNAs and circRNAs in the PD-1/PD-L1 pathway in cancer immunotherapy
    Wenxiao Jiang
    Shuya Pan
    Xin Chen
    Zhi-wei Wang
    Xueqiong Zhu
    Molecular Cancer, 20